Top Page
British American Tobacco
(LSE:BATS)
British American Tobacco (BATS) vs. iShares MSCI United Kingdom ETF (EWC)
British American Tobacco Business Overview & Revenue Model
British American Tobacco Earnings Call Summary
British American Tobacco Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B |
| Gross Profit | 21.43B | 22.39B | 22.85B | 21.09B | 21.33B |
| EBITDA | 7.74B | 13.28B | 12.38B | 11.19B | 10.71B |
| Net Income | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B |
Balance Sheet | |||||
| Total Assets | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B |
| Cash, Cash Equivalents and Short-Term Investments | 5.81B | 5.26B | 4.03B | 3.27B | 3.38B |
| Total Debt | 36.95B | 39.73B | 43.14B | 39.66B | 43.97B |
| Total Liabilities | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B |
| Stockholders Equity | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B |
Cash Flow | |||||
| Free Cash Flow | 9.52B | 10.25B | 9.87B | 9.19B | 9.28B |
| Operating Cash Flow | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B |
| Investing Cash Flow | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M |
| Financing Cash Flow | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B |
British American Tobacco Technical Analysis
British American Tobacco Risk Analysis
British American Tobacco Peers Comparison
British American Tobacco Corporate Events
British American Tobacco p.l.c. announced the repurchase of 112,660 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. The company intends to cancel these shares, which will adjust the number of shares in issue and those held in treasury. This move is part of the company’s strategy to manage its capital structure and could impact shareholder interests by potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 112,660 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The shares, purchased at an average price of 4,216.4370 pence, will be canceled, reducing the total number of shares in circulation. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its stock market performance and investor relations.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 113,078 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback programme. The company plans to cancel these shares, which will reduce the total number of shares in issue to 2,192,139,587. This move is part of a strategic effort to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executive directors and senior management have acquired ordinary shares in the company through the reinvestment of dividend income. This transaction, conducted on the London Stock Exchange, reflects the ongoing commitment of the company’s leadership to align their interests with those of shareholders, potentially impacting the company’s market perception and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its senior executives, including regional directors and the Chief Marketing Officer, have acquired ordinary shares in the company through the reinvestment of dividend income. These transactions, conducted on the London Stock Exchange, reflect the company’s ongoing commitment to aligning management interests with shareholder value. The acquisitions may enhance stakeholder confidence in the company’s financial strategies and market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced transactions involving its Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, who acquired quarterly dividend equivalent shares under the company’s Deferred Share Bonus Scheme. These transactions reflect the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced a transaction involving Holly Keller Koeppel, a Non-Executive Director, who received additional Deferred Stock Units (DSUs) linked to the company’s American Depositary Shares (ADSs). This transaction, which reflects the value of dividends declared on the underlying ADSs, highlights the company’s ongoing commitment to aligning executive compensation with shareholder interests, potentially impacting investor confidence and stakeholder engagement.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the approval and publication of a Supplementary Prospectus related to its £25 billion Euro Medium Term Note Programme. This development is significant as it reflects the company’s ongoing efforts to manage its financial strategies and maintain its market position, potentially impacting stakeholders by providing additional financial instruments for investment.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 114,500 of its ordinary shares as part of its ongoing buyback program. This move, facilitated by Banco Santander, is aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. The company plans to cancel the purchased shares, which will result in 2,192,251,968 ordinary shares remaining in issue. This strategic financial maneuver is part of BAT’s efforts to optimize its capital structure and deliver value to its shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 114,176 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its share capital and voting rights as of July 31, 2025. The company reported an issued share capital of 2,192,753,745 ordinary shares, with 133,003,645 shares held in treasury. This information is crucial for shareholders to determine their voting rights interests in compliance with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 123,745 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will impact the total number of shares in issue and may affect shareholder notifications under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £36.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a new phase in its share buyback programme, commencing on 31 July 2025 and concluding on 15 October 2025, in collaboration with Banco Santander. This initiative aims to reduce the company’s share capital by repurchasing and cancelling up to 220,451,469 shares, as authorized by its shareholders at the 2025 AGM. The buyback is structured to comply with regulatory requirements, ensuring the maximum price paid for shares adheres to specific financial guidelines. This move is expected to impact the company’s financial structure and shareholder value positively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 150,365 ordinary shares as part of its ongoing share repurchase program. This move, in line with shareholder approval, aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco’s half-year report for 2025 shows a slight decline in revenue due to currency headwinds, but an increase at constant exchange rates driven by growth in the U.S. and the success of Velo Plus. The company’s New Categories segment, which includes smokeless products, now accounts for 18.2% of total revenue, with a significant increase in contribution margin. Despite challenges in regions like APMEA, BAT remains on track to meet its full-year guidance, with plans for continued innovation and investment in high-profit areas, enhancing shareholder value through strong cash returns and share buy-backs.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £2800.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 139,813 ordinary shares as part of its ongoing share repurchase program. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 153,454 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through UBS AG London Branch, is part of the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. The cancellation of these shares will adjust the total number of shares in issue, impacting shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback, purchasing 148,792 of its ordinary shares from UBS AG London Branch as part of its ongoing buyback program. The company plans to cancel these shares, which will impact the total number of shares in issue, potentially affecting shareholder interests and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 129,938 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, authorized by shareholders, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has announced the repurchase of 129,938 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through UBS AG London Branch, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 148,403 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, is aimed at enhancing shareholder value by reducing the number of shares in circulation, which could potentially increase earnings per share and improve market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 143,017 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, is aimed at reducing the number of shares in circulation, potentially enhancing shareholder value and impacting the company’s market positioning by consolidating its equity base.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced a buyback of 137,754 ordinary shares, as part of its ongoing share repurchase program. This action, approved by shareholders, aims to enhance shareholder value and optimize the capital structure by reducing the number of shares in circulation, thereby potentially increasing earnings per share.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 152,084 of its ordinary shares as part of a buyback program, with the intention to cancel these shares. This move is part of a broader strategy to manage the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, which could impact voting rights and shareholding notifications.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 162,833 of its ordinary shares from UBS AG London Branch, as part of its ongoing buyback program. This move is intended to cancel the purchased shares, thereby reducing the number of shares in circulation and potentially increasing the value of remaining shares. The company now has 2,193,903,998 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £2900.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 129,964 of its ordinary shares at a volume-weighted average price of 3,857.0864 pence per share. This move is part of its ongoing buyback program, aimed at optimizing its capital structure and enhancing shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 124,406 of its ordinary shares as part of its ongoing buyback program. This move, executed through UBS AG London Branch, is in line with the authority granted by shareholders and aims to cancel the purchased shares, thereby potentially enhancing shareholder value and adjusting the company’s capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 123,768 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with UBS AG London Branch, reflects the company’s strategy to enhance shareholder value by reducing the number of shares in circulation, which may impact the voting rights and interests of shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco (BAT) announced changes to its Management Board, with Michael Dijanosic stepping down as Regional Director of Asia Pacific, Middle East, and Africa (APMEA) at the end of 2025. Pascale Meulemeester will succeed him, bringing extensive experience from her previous roles at Barry Callebaut Group and Mars Inc. This appointment is part of BAT’s strategic transformation to build an inclusive culture and enhance its market position in the APMEA region.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in its voting rights structure following an acquisition by The Capital Group Companies, Inc., which now holds 19.013% of the voting rights. This shift in holdings reflects an increase from the previous 18.068% and may influence the company’s decision-making processes and strategic direction.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £26.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 110,259 of its ordinary shares as part of its ongoing buyback program. The company plans to cancel these shares, which will affect the total number of shares in issue and may have implications for shareholder notifications under regulatory rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £2900.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 119,168 of its ordinary shares as part of its ongoing buyback program. The shares were bought at prices ranging from 3,553.00p to 3,657.00p and will be cancelled, reducing the total number of shares in issue. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and shareholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 169,072 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with UBS AG London Branch, is part of the company’s strategy to manage its capital structure and return value to shareholders. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially increasing the value of remaining shares. This move reflects the company’s commitment to enhancing shareholder value and could impact its market positioning by signaling financial stability and confidence in its future performance.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 141,817 of its ordinary shares as part of its ongoing buyback program. The shares were acquired at prices ranging from 3,546.00p to 3,573.00p and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting its share price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 148,863 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, conducted through UBS AG London Branch, is part of the company’s strategy to manage its share capital and potentially improve shareholder value. Following this transaction, the company will have 2,194,983,666 ordinary shares in issue, excluding treasury shares, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executive directors and managerial staff have purchased ordinary shares in the company through the Partnership Share Scheme, a HMRC-approved Share Incentive Plan. This move, involving key figures such as the Chief Executive and Chief Financial Officer, underscores the company’s commitment to aligning the interests of its leadership with those of its shareholders, potentially strengthening stakeholder confidence and reinforcing its market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 135,758 of its ordinary shares as part of a previously announced buyback program. This move, authorized by shareholders, involves the cancellation of these shares, which will reduce the total number of shares in circulation, potentially impacting shareholder value and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 149,917 of its ordinary shares as part of a buyback program, with plans to cancel these shares. This transaction, conducted through UBS AG London Branch, is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value. Following the cancellation, the company will have 2,195,268,155 ordinary shares in issue, excluding treasury shares, which may affect shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 155,147 of its ordinary shares as part of a buyback program, with the intention to cancel these shares. This move, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £2900.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of June 30, 2025, consisting of 2,195,796,448 ordinary shares with voting rights. The company also holds 133,005,360 shares in treasury. This information is crucial for shareholders to calculate their voting rights interest under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 112,561 of its ordinary shares as part of its ongoing buyback program. The shares were bought at prices ranging from 3,445.00p to 3,464.00p per share, with an average price of 3,454.5445p. The company intends to cancel these shares, which will reduce the total number of shares in issue, potentially impacting shareholder voting rights and share value. This move is part of the company’s strategy to manage its capital structure and return value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 113,222 of its ordinary shares as part of a buyback program, with the intention to cancel these shares. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure, potentially impacting shareholder value and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced an extension to its share buyback programme, increasing the total repurchase amount to £1.1 billion by the end of 2025. This extension is funded by the proceeds from a block trade of shares in ITC Limited. The buyback aims to reduce the company’s share capital, with shares purchased to be cancelled, reflecting a strategic move to enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 108,775 of its ordinary shares as part of its ongoing buyback program. The company intends to cancel these shares, which will result in a reduction of its total shares in issue to 2,195,796,448, excluding treasury shares. This move is likely to impact shareholder interests and aligns with the company’s strategy to manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 92,400 ordinary shares as part of its ongoing buyback program. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights and interest notifications.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 86,471 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation, which may influence shareholder notifications under FCA rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £32.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC has executed a share buyback, purchasing 83,710 of its ordinary shares at an average price of 3,607.7966 pence per share. This move, part of a previously announced buyback program, aims to cancel the acquired shares, potentially impacting shareholder interests and the company’s share capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 85,202 of its ordinary shares as part of its ongoing buyback program. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and provide value to shareholders. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights and interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the sale of shares by James Barrett, Director of Business Development. The transaction, which involved the sale of 4,915 ordinary shares at a price of £36.73274 each, took place on the London Stock Exchange, totaling £180,541.417. This notification highlights the company’s ongoing transparency in disclosing managerial transactions, which could impact stakeholder perceptions and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 91,350 of its ordinary shares as part of its ongoing buyback program. The shares were purchased at a volume-weighted average price of 3,648.8058 pence per share and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to enhance shareholder value and manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has announced the repurchase of 86,453 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase and cancellation of 89,586 ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, is expected to impact the company’s share capital structure, potentially influencing shareholder interests and market perceptions.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the details of its August 2025 dividend payment, which is part of a previously declared interim dividend for the year ended December 2024. The dividend will be paid to shareholders on the UK main register and the South Africa branch register, with specific exchange rates and tax implications for South African shareholders. This announcement reinforces the company’s commitment to returning value to its shareholders, while also highlighting the financial implications for those on the South Africa branch register due to currency exchange and tax considerations.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 87,819 of its ordinary shares as part of a buyback program, with the intention to cancel these shares. This move will reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 87,960 ordinary shares at an average price of 3,565.8640 pence per share. This move, authorized by shareholders, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially enhancing shareholder value. The transaction reflects the company’s strategic financial management and could impact shareholder interests by altering voting rights and shareholding structures.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC announced the purchase of 115,990 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure. The purchased shares will be canceled, reducing the number of shares in circulation and potentially increasing shareholder value by boosting earnings per share. This move reflects the company’s commitment to returning value to shareholders and maintaining a strong market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 115,438 of its ordinary shares as part of a buyback program, with plans to cancel these shares. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its share capital and could impact shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in the voting rights of its shares, following an acquisition by The Capital Group Companies, Inc. This acquisition has increased the voting rights held by The Capital Group to 18.068752%, up from a previous 17.017042%. This change reflects a significant shift in shareholder influence, potentially impacting company decisions and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 115,251 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and strengthening the company’s market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 119,037 of its ordinary shares at an average price of 3,451.0771 pence per share. This move is part of a broader buyback program and aims to cancel the purchased shares, potentially impacting the company’s share value and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of ordinary shares by several of its top executives, including the Chief Executive, Chief Financial Officer, and other directors, under the Partnership Share Scheme. This move, conducted on the London Stock Exchange, demonstrates the company’s commitment to aligning the interests of its management with those of its shareholders, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 123,502 of its ordinary shares as part of its ongoing buyback program. The shares, purchased from Merrill Lynch International, will be canceled, reducing the total number of shares in issue and potentially increasing shareholder value. This move is part of the company’s strategy to optimize its capital structure and return value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 123,294 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value, potentially impacting its share price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the repurchase of 119,368 of its ordinary shares, as part of a buyback program authorized by shareholders. The shares were purchased from Merrill Lynch International and will be canceled, reducing the total number of shares in issue to 2,197,514,957. This move is part of the company’s strategy to manage its capital structure and may impact shareholder interests as it adjusts the number of shares carrying voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has reported that its revenue performance for the first half of 2025 is slightly ahead of previous guidance, with expectations for full-year revenue growth of 1-2%. The company anticipates a return to revenue and profit growth in the U.S., driven by strong performance in its combustibles and modern oral segments, despite challenges in the vapour category due to illicit products. BAT is focusing on deploying new innovations in key markets to drive growth in the second half of the year. The company is also working towards financial flexibility by partially monetizing its ITC stake and committing to reducing leverage by 2026, while maintaining a progressive dividend and share buy-back program.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of May 30, 2025, which consists of over 2.19 billion ordinary shares, with a significant portion held in treasury. This update is crucial for shareholders to calculate their voting rights and any changes in their interest, aligning with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 125,822 of its ordinary shares at a volume-weighted average price of 3,330.6572 pence per share. The company intends to cancel these shares, reducing the total number of shares in issue to 2,197,634,325, which may impact shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 126,884 ordinary shares at an average price of 3,309.5614 pence per share. This move, authorized by shareholders, is part of the company’s ongoing buyback program and will result in the cancellation of these shares, reducing the total number of shares in circulation. This action is likely to impact shareholder value by potentially increasing earnings per share and reflects the company’s commitment to returning value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 123,456 of its ordinary shares at an average price of 3,333.2523 pence per share. This move, authorized by shareholders, is part of a broader buyback program and will result in the cancellation of the purchased shares, reducing the number of shares in circulation and potentially enhancing shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has completed a block trade of 313 million ordinary shares in ITC Limited, raising approximately £1.05 billion. The proceeds will enhance BAT’s financial flexibility, support its transformation investments, and extend its share buyback program by £200 million, totaling £1.1 billion in repurchases for 2025. This move is expected to bolster shareholder returns and strengthen BAT’s market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 121,839 of its ordinary shares at a volume-weighted average price of 3,327.8563 pence per share. This move, authorized by shareholders, is part of a broader strategy to optimize capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and require notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the sale of approximately 2.3% of its shares in ITC Limited through an accelerated bookbuild process to institutional investors. This transaction aims to provide BAT with increased financial flexibility, supporting its commitment to transformation, deleveraging, and sustainable shareholder returns. The proceeds will help BAT reach its target leverage corridor by 2026 and increase its share buyback program. Despite the sale, BAT will maintain a significant 23.1% stake in ITC and continues to view ITC as a strategic partner in India, a market with long-term growth potential.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco (BAT) is considering the sale of a portion of its shareholding in ITC Limited through an on-market trade. While the company evaluates this potential disposal, there is no certainty regarding the transaction’s execution or terms. This move could impact BAT’s financial strategy and market positioning, as it continues to focus on its smokeless product portfolio and sustainability goals.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 127,368 of its own ordinary shares as part of its ongoing buyback program. This transaction, conducted with Merrill Lynch International, is part of a strategy to reduce the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 126,670 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, aims to reduce the number of shares in circulation, potentially enhancing shareholder value and adjusting the company’s capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has disclosed a transaction involving James Barrett, Director of Business Development, who transferred 4,915 ordinary shares between his own accounts for nil consideration. This transaction, conducted outside a trading venue, reflects internal adjustments and does not directly impact the company’s market operations or stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 127,404 of its ordinary shares as part of a buyback program, with plans to cancel these shares. This move is intended to optimize the company’s capital structure and could potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback program, purchasing 130,580 of its ordinary shares at an average price of 3,213.57 pence per share. This move is part of a broader strategy to enhance shareholder value, as the company plans to cancel these shares, thereby reducing the total number of shares in circulation and potentially increasing the value of remaining shares.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in its voting rights structure, with Spring Mountain Investments Ltd now holding 5.251446% of the voting rights. This adjustment, down from a previous position of 6.971493%, reflects a significant shift in shareholder influence and could impact the company’s strategic decisions and stakeholder dynamics.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 133,097 of its ordinary shares at a volume-weighted average price of 3,147.6540 pence per share. This move is part of the company’s ongoing buyback program and aims to reduce the number of shares in circulation, potentially enhancing shareholder value. Following the cancellation of these shares, the company will have 2,198,637,109 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 137,397 of its ordinary shares as part of a buyback program, with the highest price paid per share being 3,071 pence. The company intends to cancel these shares, reducing the number of shares in circulation, which may impact shareholder notifications under FCA rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 138,569 ordinary shares at an average price of 3,030.7749 pence per share. This move, part of a broader buyback program, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. The transaction reflects the company’s strategic focus on enhancing shareholder returns and optimizing its capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback, purchasing 135,953 of its ordinary shares as part of a program authorized by shareholders. This move, involving the cancellation of the acquired shares, aims to optimize the company’s capital structure and potentially enhance shareholder value. Following this transaction, the company will have 2,199,044,110 ordinary shares in issue, excluding treasury shares, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the acquisition of shares by its Chief Executive, Tadeu Marroco, and Luciana Franco Do Amaral, a person closely associated with him. The transaction, conducted on the London Stock Exchange, involved the reinvestment of dividend income to acquire ordinary shares, highlighting a strategic move to strengthen their stake in the company.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 135,845 ordinary shares at prices ranging from 3,050.00p to 3,150.00p, with an average of 3,090.1409p per share. This move, part of a previously announced buyback program, aims to cancel the purchased shares, thereby reducing the number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,199,172,149 shares in issue and 133,013,619 shares held in treasury, impacting shareholder notifications under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in its voting rights structure following an acquisition or disposal of voting rights by Spring Mountain Investments Ltd. The transaction has resulted in Spring Mountain Investments Ltd holding 6.971493% of the voting rights, down from a previous 7.285760%. This adjustment in voting rights could influence the company’s governance and decision-making processes, impacting stakeholders and potentially affecting the company’s strategic direction.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving Jerome Abelman, the Director, Legal and General Counsel, who acquired shares following the exercise of options under the 2020 British American Tobacco 5 Year Sharesave Scheme. The transaction involved the acquisition of 1,249 ordinary shares at a total price of £29,988.49, conducted outside a trading venue on May 8, 2025. This transaction reflects the company’s ongoing commitment to employee share ownership, potentially impacting stakeholder perceptions and aligning managerial interests with shareholder value.
British American Tobacco announced the repurchase of 132,387 of its ordinary shares as part of its ongoing buyback program. This move, executed through Merrill Lynch International, reflects the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights.
British American Tobacco has announced a change in major holdings, with Spring Mountain Investments Ltd now holding 7.285760% of the voting rights. This adjustment in holdings could influence the company’s strategic decisions and impact its stakeholders, reflecting a shift in the control dynamics within the company.
British American Tobacco announced that several of its executives, including the CEO and COO, have acquired ordinary shares through the reinvestment of dividend income as part of the company’s Share Incentive Plan. This move reflects the company’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially strengthening stakeholder confidence and enhancing market positioning.
British American Tobacco announced that several of its senior executives, including regional directors and the Chief Marketing Officer, have acquired ordinary shares in the company through the reinvestment of dividend income. This transaction, conducted on May 7, 2025, on the London Stock Exchange, reflects the company’s ongoing commitment to aligning the interests of its leadership with those of its shareholders, potentially strengthening stakeholder confidence.
British American Tobacco has announced transactions involving its Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, who acquired shares under the company’s Deferred Share Bonus Scheme and Long-Term Incentive Plan. These transactions, which took place outside a trading venue, reflect the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting the company’s market positioning and stakeholder confidence.
British American Tobacco has announced a transaction involving the credit of additional Deferred Stock Units (DSUs) to Non-Executive Director Holly Keller Koeppel. This transaction is linked to the value of dividends declared on the company’s American Depositary Shares (ADSs) and is part of the Reynolds American Inc. Amended and Restated Deferred Compensation Plan. The transaction, which took place outside a trading venue, reflects the company’s ongoing commitment to aligning executive compensation with shareholder interests.
British American Tobacco has repurchased 127,462 of its ordinary shares as part of a buyback program authorized by shareholders. This move, involving shares purchased at an average price of 3,287.2119 pence, is intended to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests.
British American Tobacco has announced a transaction involving Paul McCrory, Director of Corporate & Regulatory Affairs, who acquired shares following the exercise of options under the 2022 Sharesave Scheme. This transaction, involving 660 ordinary shares at a price of £17,998.20, reflects ongoing managerial engagement with the company’s equity, potentially impacting stakeholder perceptions of executive confidence in the company’s future performance.
British American Tobacco has announced a transaction involving the transfer of 3,332 ordinary shares from James Murphy, Director of Research and Science, to Kirsti Nordgard Murphy, a person closely associated with him. The transaction was conducted outside a trading venue and was reported as an initial notification. This transfer of shares highlights internal movements within the company’s managerial responsibilities, potentially impacting stakeholders’ perceptions of corporate governance and internal control.
British American Tobacco has announced that several of its executive directors and senior managers, including the Chief Executive and Chief Financial Officer, have purchased ordinary shares in the company through the Partnership Share Scheme. This move, conducted on the London Stock Exchange, reflects a commitment to align the interests of the company’s leadership with those of its shareholders, potentially impacting the company’s market perception and stakeholder confidence.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 126,860 of its ordinary shares at an average price of 3,308.6193 pence per share. This move is part of a broader buyback program and will result in the cancellation of these shares, reducing the total number of shares in circulation and potentially impacting shareholder value and voting rights.
British American Tobacco p.l.c. announced the repurchase of 127,236 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share. The cancellation of these shares will adjust the total number of shares in issue, which could impact shareholder notifications under regulatory rules.